TABLE 1.

Sample size of five vaccination strategies from eight cell types.

Cell type	COVID-19 vaccination strategy	Sample size
Blood B cells	Non-vaccinated	316
	Adenovirus vaccine + Adenovirus vaccine	524
	Attenuated vaccine + Attenuated vaccine	1,018
	mRNA vaccine + mRNA vaccine	547
	mRNA vaccine + Attenuated vaccine	722
Blood T cells	Non-vaccinated	90
	Adenovirus vaccine + Adenovirus vaccine	242
	Attenuated vaccine + Attenuated vaccine	523
	mRNA vaccine + mRNA vaccine	272
	mRNA vaccine + Attenuated vaccine	306
Nasal B cells	Non-vaccinated	88
	Adenovirus vaccine + Adenovirus vaccine	38
	Attenuated vaccine + Attenuated vaccine	20
	mRNA vaccine + mRNA vaccine	61
	mRNA vaccine + Attenuated vaccine	96
Nasal T cells	Non-vaccinated	54
	Adenovirus vaccine + Adenovirus vaccine	43
	Attenuated vaccine + Attenuated vaccine	12
	mRNA vaccine + mRNA vaccine	45
	mRNA vaccine + Attenuated vaccine	61
Nasal macrophages	Non-vaccinated	417
	Adenovirus vaccine + Adenovirus vaccine	303
	Attenuated vaccine + Attenuated vaccine	45
	mRNA vaccine + mRNA vaccine	180
	mRNA vaccine + Attenuated vaccine	205
Lung macrophages	Non-vaccinated	1,437
	Adenovirus vaccine + Adenovirus vaccine	804
	Attenuated vaccine + Attenuated vaccine	753
	mRNA vaccine + mRNA vaccine	1,030
	mRNA vaccine + Attenuated vaccine	645
Alveolar epithelial cells	Non-vaccinated	614
	Adenovirus vaccine + Adenovirus vaccine	481
	Attenuated vaccine + Attenuated vaccine	481
	mRNA vaccine + mRNA vaccine	356
	mRNA vaccine + Attenuated vaccine	286
Lung endothelial cells	Non-vaccinated	869
	Adenovirus vaccine + Adenovirus vaccine	527
	Attenuated vaccine + Attenuated vaccine	724
	mRNA vaccine + mRNA vaccine	362
	mRNA vaccine + Attenuated vaccine	322